A new chapter of the widely appreciated India Pharma Week by UBM India concurrently began at the India Expo Centre, Greater Noida
South Asia’s largest Pharma event with over 1,600 exhibitors from 42 countries
More than 7 eclectic engagements form a part of the India Pharma Week magnum opus
The reputed CPhI Global Pharma Index ranks India no. 1 in terms of pharma market growth potential, and within the top 3 countries on the parameter of competitiveness. India has also taken giant strides to increase its global reputation.
UBM India, India’s leading B2B exhibition organizer, today launched the 12th edition of South Asia’s largest Pharma event, the CPhI & P-MEC India expo, a three-day show, from December 12th- 14th, 2018, at the India Expo Centre, Greater Noida, Delhi-NCR. The signature expo has been comprehensively assisted in its endeavors by governing bodies such as Pharmexcil, CIPI and IDMA. This year’s edition witnessed participation from more than 1,600 exhibitors from 42 countries. Special pavilions by Pharmaceuticals Export Promotion Council of India (Pharmexcil), China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) and China Council for the Promotion of International Trade (CCPIT) formed an intrinsic part of the expo.